# BLSM (BlossomHill Therapeutics, Inc.) - SEC EDGAR Financial Statements

> BlossomHill Therapeutics, Inc. reported $124.1M in total assets through June 30, 2026 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/BLSM
- Markdown: https://convexityos.com/fundamentals/BLSM.md
- SEC CIK: 0001839970
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:37 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001839970&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | -- | Jun 30, 2026 |
| Operating Income | FY 2026 | -- | Operating profit |
| Net Income | FY 2026 | -- | GAAP bottom line |
| Diluted EPS | FY 2026 | -- | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Jun 30, 2026 | $95.38M | Total debt: $1.15M |

## Income Statement

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Sep 2025 | Jun 2025 |
| --- | --- | --- | --- | --- |
| Research & Development | $21.93M | $21.36M | $14.67M | $12.53M |
| Total Operating Expenses | $25.48M | $24.67M | $16.73M | $14.10M |
| **Operating Income** | -$25.48M | -$24.67M | -$16.73M | -$14.10M |
| **Net Income** | -$24.01M | -$23.76M | -$15.98M | -$13.24M |
| Basic EPS | -$1.29 | -$8.75 | -$6.54 | -$5.51 |
| **Diluted EPS** | -$1.29 | -$8.75 | -$6.54 | -$5.51 |
| Basic Shares Outstanding | 18.6M | 2.7M | 2.4M | 2.4M |
| Diluted Shares Outstanding | 18.6M | 2.7M | 2.4M | 2.4M |

## Balance Sheet

### Balance Sheet (Quarterly)

| Line Item | Jun 2026 | Dec 2025 |
| --- | --- | --- |
| Cash & Cash Equivalents | $95.38M | $136.7M |
| **Cash & Short-Term Investments** | $95.38M | $136.7M |
| **Total Current Assets** | $101.0M | $138.8M |
| Property, Plant & Equipment, Net | $1.49M | $1.73M |
| Other Non-Current Assets | $2.48M | $2.50M |
| **Total Non-Current Assets** | $23.16M | $24.14M |
| **Total Assets** | $124.1M | $163.0M |
| Accounts Payable | $3.93M | $2.31M |
| Other Current Liabilities | $809K | $0 |
| **Total Current Liabilities** | $18.62M | $15.48M |
| Other Non-Current Liabilities | $1.25M | $0 |
| **Total Non-Current Liabilities** | $23.47M | $22.39M |
| **Total Liabilities** | $42.09M | $37.87M |
| **Total Debt (incl. Leases)** | $1.15M | $5.0K |
| Common Stock | $1.0K | $1.0K |
| Retained Earnings | -$179.8M | -$135.0M |
| **Total Stockholders' Equity** | -$174.8M | -$131.7M |
| Total Equity | -$174.8M | -$131.7M |

## Cash Flow Statement

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Sep 2025 | Jun 2025 |
| --- | --- | --- | --- | --- |
| Net Income | -$24.01M | -$23.76M | -$15.98M | -$13.24M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Sep 2025 | Jun 2025 |
| --- | --- | --- | --- | --- |
| Current Ratio | -- | 5.42x | -- | -- |
| Quick Ratio | -- | 5.12x | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
